The CUT&RUN Suspect List of Problematic Regions of the Genome
Overview
Affiliations
Background: Cleavage Under Targets and Release Using Nuclease (CUT&RUN) is an increasingly popular technique to map genome-wide binding profiles of histone modifications, transcription factors, and co-factors. The ENCODE project and others have compiled blacklists for ChIP-seq which have been widely adopted: these lists contain regions of high and unstructured signal, regardless of cell type or protein target, indicating that these are false positives. While CUT&RUN obtains similar results to ChIP-seq, its biochemistry and subsequent data analyses are different. We found that this results in a CUT&RUN-specific set of undesired high-signal regions.
Results: We compile suspect lists based on CUT&RUN data for the human and mouse genomes, identifying regions consistently called as peaks in negative controls. Using published CUT&RUN data from our and other labs, we show that the CUT&RUN suspect regions can persist even when peak calling is performed with SEACR or MACS2 against a negative control and after ENCODE blacklist removal. Moreover, we experimentally validate the CUT&RUN suspect lists by performing reiterative negative control experiments in which no specific protein is targeted, showing that they capture more than 80% of the peaks identified.
Conclusions: We propose that removing these problematic regions can substantially improve peak calling in CUT&RUN experiments, resulting in more reliable datasets.
Wall B, Ogata J, Nguyen M, McClay J, Harrell J, Dozmorov M bioRxiv. 2025; .
PMID: 39975128 PMC: 11839099. DOI: 10.1101/2025.02.06.636968.
Khadka S, Lukas B, Sun C, Muralimanoharan S, Shanmugasundaram K, Khosh A J Mol Med (Berl). 2025; 103(3):311-326.
PMID: 39904883 PMC: 11880082. DOI: 10.1007/s00109-025-02517-0.
Nornes S, Bruche S, Adak N, McCracken I, De Val S Elife. 2025; 14.
PMID: 39819837 PMC: 11896612. DOI: 10.7554/eLife.102440.
Khadka S, Lukas B, Sun C, Muralimanoharan S, Shanmugasundaram K, Khosh A Res Sq. 2025; .
PMID: 39764110 PMC: 11702794. DOI: 10.21203/rs.3.rs-5125876/v1.
TGFβ signaling sensitizes MEKi-resistant human melanoma to targeted therapy-induced apoptosis.
Loos B, Salas-Bastos A, Nordin A, Debbache J, Stierli S, Cheng P Cell Death Dis. 2024; 15(12):925.
PMID: 39709491 PMC: 11663225. DOI: 10.1038/s41419-024-07305-1.